Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-14 Sale |
2025-04-16 5:39 pm |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $35 | $350,000 | 76,921 (Direct) |
View |
| 2025-04-01 Sale |
2025-04-03 5:11 pm |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $34.05 | $1,021,500 | 86,921 (Direct) |
View |
| 2025-03-25 Sale |
2025-03-27 4:54 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
75,000 | $36.87 | $2,764,943 | 6,155,851 (Indirect Direct) |
View |
| 2025-03-06 Sale |
2025-03-10 4:43 pm |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $32.58 | $419,500 | 43,823 (Indirect Direct) |
View |
| 2025-03-05 Sale |
2025-03-07 6:09 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
6,000,000 | $32.96 | $197,760,000 | 19,260,971 (Indirect) |
View |
| 2025-02-25 Sale |
2025-02-27 5:36 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $33.19 | $282,115 | 542,634 (Direct) |
View |
| 2025-02-25 Sale |
2025-02-27 5:12 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
75,000 | $33.57 | $2,517,971 | 6,230,851 (Indirect Direct) |
View |
| 2025-02-19 Sale |
2025-02-19 8:50 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
4,148 | $36.16 | $149,973 | 324,710 (Direct) |
View |
| 2025-02-19 Sale |
2025-02-19 8:48 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
31,543 | $36.14 | $1,140,024 | 6,809,394 (Indirect Direct) |
View |
| 2025-01-31 Sale |
2025-01-31 7:18 pm |
BridgeBio Pharma Inc. | BBIO | VIKING GLOBAL INVESTORS LP Viking Global Opportunities Parent GP LLC Viking Global Opportunities GP LLC Viking Global Opportunities Portfolio GP LLC Viking Global Opportunities Illiquid Investments Sub-Master LP HALVORSEN OLE ANDREAS Ott David C. Shabet Rose Sharon 10% Owner |
3,065,616 | $34.9 | $106,989,998 | 22,055,375 (Indirect) |
View |
| 2025-01-28 Sale |
2025-01-30 6:31 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
68,000 | $36.29 | $2,467,761 | 542,428 (Direct) |
View |
| 2025-01-28 Sale |
2025-01-30 6:29 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
600,000 | $36.31 | $21,788,650 | 6,305,851 (Indirect Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 8:00 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
27,389 | $22.41 | $613,826 | 6,905,851 (Indirect Direct) |
View |
| 2024-11-19 Sale |
2024-11-20 7:57 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
4,156 | $22.41 | $93,137 | 93,758 (Direct) |
View |
| 2024-09-13 Sale |
2024-09-17 6:44 pm |
BridgeBio Pharma Inc. | BBIO | KKR Genetic Disorder L.P. KKR Genetic Disorder GP LLC KKR Group Partnership L.P. KKR Group Holdings Corp. KKR Group Co. Inc. KKR & Co. Inc. KKR Management LLP KRAVIS HENRY R ROBERTS GEORGE R 10% Owner |
5,800,000 | $25.75 | $149,350,000 | 25,260,971 (Indirect) |
View |
| 2024-08-19 Sale |
2024-08-20 6:31 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
27,389 | $24.69 | $676,256 | 7,520,470 (Indirect Direct) |
View |
| 2024-08-19 Sale |
2024-08-20 6:27 pm |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
4,155 | $24.69 | $102,590 | 359,035 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-14 Exercise |
2025-04-16 5:39 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $0 | 76,921 (Direct) |
View |
| 2025-04-14 Exercise |
2025-04-16 5:39 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
10,000 | $8.45 | 76,921 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:11 pm |
N/A 2032-06-22 |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $0 | 86,921 (Direct) |
View |
| 2025-04-01 Exercise |
2025-04-03 5:11 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Ellis Andrea Director |
30,000 | $8.45 | 86,921 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:32 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and CFO |
109,100 | $0 | 523,305 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:09 pm |
N/A 2035-03-18 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
256,068 | $0 | 256,068 (Direct) |
View |
| 2025-03-19 Option Award |
2025-03-21 6:03 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
23,660 | $0 | 148,665 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 4:43 pm |
N/A 2033-06-21 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $0 | 43,823 (Direct) |
View |
| 2025-03-06 Exercise |
2025-03-10 4:43 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
12,875 | $16.75 | 43,823 (Direct) |
View |
Ownership |
2025-02-27 8:22 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Apuli Maricel Chief Accounting Officer |
0 | $0 | 125,005 (Direct) |
View |
| 2025-02-25 Exercise |
2025-02-27 5:36 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $0 | 542,634 (Direct) |
View |
| 2025-02-25 Exercise |
2025-02-27 5:36 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C CFO and Treasurer |
8,500 | $17 | 542,634 (Direct) |
View |
| 2025-02-16 Tax Withholding |
2025-02-19 8:51 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
13,782 | $34.9 | 414,205 (Direct) |
View |
| 2025-02-16 Tax Withholding |
2025-02-19 8:50 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
13,102 | $34.9 | 324,710 (Direct) |
View |
| 2025-02-16 Exercise |
2025-02-19 8:50 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
51,596 | $0 | 324,710 (Direct) |
View |
| 2025-02-16 Tax Withholding |
2025-02-19 8:48 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
23,996 | $34.9 | 6,809,394 (Direct) |
View |
| 2025-02-16 Exercise |
2025-02-19 8:48 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
111,078 | $0 | 6,809,394 (Direct) |
View |
| 2025-01-28 Exercise |
2025-01-30 6:31 pm |
N/A 2029-06-26 |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
68,000 | $0 | 542,428 (Direct) |
View |
| 2025-01-28 Exercise |
2025-01-30 6:31 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
68,000 | $17 | 542,428 (Direct) |
View |
| 2024-12-26 Gift(A) |
2025-01-08 5:43 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
7,400 | $0 | 1,092,665 (Direct) |
View |
| 2024-12-30 Exercise |
2024-12-31 5:52 pm |
N/A 2028-07-01 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
159,404 | $0 | 159,404 (Direct) |
View |
| 2024-12-30 Exercise |
2024-12-31 5:52 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
39,851 | $26.21 | 159,404 (Direct) |
View |
| 2024-12-30 Exercise |
2024-12-31 5:52 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
39,851 | $16.68 | 159,404 (Direct) |
View |
| 2024-12-30 Exercise |
2024-12-31 5:52 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
79,702 | $10.99 | 159,404 (Direct) |
View |
| 2024-12-26 Gift |
2024-12-27 7:18 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | MCCORMICK FRANK Director |
7,400 | $0 | 1,092,665 (Direct) |
View |
| 2024-12-24 Gift |
2024-12-27 7:05 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
4,685,725 | $0 | 6,905,851 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 7:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
121,951 | $0 | 121,951 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 7:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
42,683 | $0 | 42,683 (Direct) |
View |
| 2024-12-10 Option Award |
2024-12-12 7:00 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
50,000 | $0 | 427,987 (Direct) |
View |
| 2024-11-16 Exercise |
2024-11-19 6:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
111,074 | $0 | 7,492,322 (Direct) |
View |
| 2024-11-16 Tax Withholding |
2024-11-19 6:15 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
28,148 | $23.72 | 7,492,322 (Direct) |
View |
| 2024-11-16 Tax Withholding |
2024-11-19 6:13 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
17,936 | $23.72 | 377,987 (Direct) |
View |
| 2024-11-16 Exercise |
2024-11-19 6:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
51,598 | $0 | 345,958 (Direct) |
View |
| 2024-11-16 Tax Withholding |
2024-11-19 6:06 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
13,077 | $23.72 | 345,958 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 6:31 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
111,074 | $0 | 7,520,470 (Direct) |
View |
| 2024-08-16 Tax Withholding |
2024-08-20 6:31 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Kumar Neil Chief Executive Officer |
28,148 | $24.4 | 7,520,470 (Direct) |
View |
| 2024-08-16 Exercise |
2024-08-20 6:27 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
51,594 | $0 | 359,035 (Direct) |
View |
| 2024-08-16 Tax Withholding |
2024-08-20 6:27 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | STEPHENSON BRIAN C Secretary, Treasurer & CFO |
13,077 | $24.4 | 359,035 (Direct) |
View |
| 2024-08-16 Tax Withholding |
2024-08-20 6:24 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
17,936 | $24.4 | 395,923 (Direct) |
View |
| 2024-08-06 Option Award |
2024-08-08 4:39 pm |
N/A 2034-08-05 |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
22,163 | $0 | 417,019 (Direct) |
View |
Ownership |
2024-07-29 8:16 pm |
N/A N/A |
BridgeBio Pharma Inc. | BBIO | Trimarchi Thomas President and COO |
0 | $0 | 706,547 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:42 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Valantine Hannah Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:42 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Scott Randal W. Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:40 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Satvat Ali J. Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:39 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | MOMTAZEE JAMES C Director |
26,014 | $0 | 26,014 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-25 5:39 pm |
N/A 2034-06-20 |
BridgeBio Pharma Inc. | BBIO | Hassan Fred Director |
26,014 | $0 | 26,014 (Direct) |
View |